IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RAZINI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.323
NA - Nord America 2.920
AS - Asia 2.869
Continente sconosciuto - Info sul continente non disponibili 501
SA - Sud America 307
AF - Africa 52
OC - Oceania 9
Totale 9.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.784
CN - Cina 926
SG - Singapore 894
GB - Regno Unito 887
DE - Germania 529
IT - Italia 433
SE - Svezia 385
HK - Hong Kong 292
RU - Federazione Russa 291
BR - Brasile 220
NL - Olanda 210
IN - India 154
BD - Bangladesh 137
FR - Francia 132
UA - Ucraina 131
TR - Turchia 124
VN - Vietnam 113
CA - Canada 98
KR - Corea 94
FI - Finlandia 81
IE - Irlanda 77
EU - Europa 75
PL - Polonia 54
CO - Colombia 39
JP - Giappone 28
GR - Grecia 24
CI - Costa d'Avorio 21
ID - Indonesia 19
DK - Danimarca 18
BE - Belgio 17
AR - Argentina 16
IQ - Iraq 15
MX - Messico 15
PH - Filippine 13
ES - Italia 12
RO - Romania 11
ZA - Sudafrica 10
VE - Venezuela 8
AU - Australia 7
CL - Cile 7
UZ - Uzbekistan 7
CR - Costa Rica 6
EC - Ecuador 6
MA - Marocco 6
SA - Arabia Saudita 6
AT - Austria 5
CH - Svizzera 5
IL - Israele 5
JM - Giamaica 5
AZ - Azerbaigian 4
IR - Iran 4
PK - Pakistan 4
PY - Paraguay 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
KE - Kenya 3
LB - Libano 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
UY - Uruguay 3
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
AI - Anguilla 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
GT - Guatemala 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SO - Somalia 1
TL - Timor Orientale 1
UG - Uganda 1
VG - Isole Vergini Britanniche 1
Totale 9.555
Salva come PNG Salva come JPEG
Città #
Southend 802
Singapore 539
Hong Kong 278
Ashburn 262
Chandler 247
Beijing 238
Frankfurt am Main 205
San Jose 165
Santa Clara 140
Princeton 119
Seattle 118
Milan 113
Wilmington 104
Jacksonville 96
Mountain View 88
Los Angeles 80
Council Bluffs 77
Dublin 76
Dallas 73
Redmond 70
Ann Arbor 66
Nanjing 66
Boardman 65
Bengaluru 60
Phoenix 58
Moscow 56
Toronto 54
Warsaw 52
Lauterbourg 49
Munich 48
Dearborn 44
Sakarya 44
New York 43
Buffalo 42
Medford 37
Des Moines 36
Guangzhou 35
Andover 34
Shanghai 34
Bogotá 32
Fairfield 30
Serra 30
Ho Chi Minh City 29
Somerville 29
Helsinki 28
Tianjin 26
Woodbridge 25
Athens 23
Hanoi 23
Abidjan 21
Eitensheim 21
Jinan 21
Mumbai 20
Rome 20
Changsha 19
Fuzhou 19
Tokyo 19
Hamburg 18
Houston 18
Nanchang 17
Shenyang 17
Sunnyvale 17
São Paulo 17
Brussels 15
Hangzhou 15
Odernheim 15
Chicago 13
Hebei 13
Roxbury 12
Columbus 11
Falkenstein 11
Falls Church 11
The Dalles 11
Zhengzhou 11
Haikou 10
London 10
Bitonto 9
Cangzhou 9
Jiaxing 9
Orem 9
Quanzhou 9
San Diego 9
Nürnberg 8
Ottawa 8
Portici 8
Porto Alegre 8
Redwood City 8
Seoul 8
Brooklyn 7
Hefei 7
Istanbul 7
Kunming 7
Lanzhou 7
Norwalk 7
Portsmouth 7
Cambridge 6
Jakarta 6
Mainz 6
Naples 6
Ningbo 6
Totale 5.691
Salva come PNG Salva come JPEG
Nome #
Modificazione genica di cellule staminali distrofiche allo scopo di trapianto autologo nella distrofia muscolare di Duchenne 339
Impaired Angiogenic Potential of Human Placental Mesenchymal Stromal Cells in Intrauterine Growth Restriction 329
Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle 297
Stem cells and muscular dystrophies 249
Combining Stem Cell and Exon Skipping Approach to Treat Muscular Dystrophies 236
CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells 234
Stem cell-mediated exon skipping of the dystrophin gene by the bystander effect 231
Heterogeneous tumorigenic capacity of human brain tumor derived neurospheres 229
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 226
Role of mesenchymal stem cells in human IUGR placentas 221
Development of a new technique for muscle tissues-stem cells co-colture 213
Autologous transplantation of bone marrow-derived CD133+ stem cells in facioscapulohumeral dystrophy 212
Stem Cell Salvage of injured peripheral nerve 211
Perspectives of Stem Cell Therapy in Duchenne Muscular Dystrophy 210
Heterogeneous tumorigenic capacity of human brain tumor derived neurospheres 208
Heterogeneous tumourogenic ability of human brain tumour derived neurospheres 208
Combining gene and stem cell therapy in the treatment of disferlinopaties 208
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 204
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy 201
In Vivo Tracking of Stem cell by Nanotechnologies : Future Prospect for Mouse to Human Translation 201
Full-length dysferlin expression driven by engineered human dystrophic blood-derived CD133+ stem cells 196
Development of new technologies Including myogenic differentiation of human circulating CD133+cells 195
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy. 194
Cell Therapy of Muscular Dystrophy with Engineered CD133+ Cells 193
Cell Theraphy of Muscolar Dystrophy with Engineered CD133+Cell 193
Ex vivo expansion of human circulating CD133+ progenitors cells: promising tool for cell-based therapeutic approaches in muscular dystrophy. 191
Combining Gene and Stem Cell therapy in the Treatment of Dysferlinophaties 187
Ex vivo expansion of peripheral blood CD133+ progenitors cells: promising tool for cell-based therapeutic approaches in muscular dystrophy. 181
Preclinical experience and perspectives of a clinical trial using cD133 stem cells 181
Cell Based Therapy for Duchenne Muscular Dystrophy 178
Exon-skipping of dysferlin in CD133+ stem cells isolated from normal and patient affected with dysferlinopathies. 176
Proliferation and Clonal Analysis of Muscle Derived CD133+ Stem Cell Subpopulations Define a Depletion of Mesenchymal Population in DMD Patients 174
Proliferation and clonal characterization of human muscle derived CD133+ positive stem cells define an intrinsic heterogeneity 172
Development of New technologies Inducing Myogenic Differentiation of Human Circulating CD133+ Cells 170
Combining Stem Cells and Exon-Skipping and Approch to Treat Muscular Dystrophies 168
Myogenic differentiation potential of CD133+ stem cells isolated from various sources 167
Differential Activation of CD20-related Signaling Pathways Results in distinct differentiation behaviour of normal and DMD circulating CD133+ Stem Cells 165
Muscle Cell Sheet-polymer Film generation and Transplantation for the Treatment of Muscular Dystrophy 165
Human Fetal CD133+ Muscle Cells Expressing Perycite Markers Repair Dystrophic Muscle Tissue. 160
Perturbation of calcium handling in CD133+ stem cells isolated from DMD blood 155
X-Ray Synchrotron-Radiation Phase-Contras Analysis of Human and Mouse Progenitors in Culture on Engineering Scaffolds 148
Stem Cell Tracking by Nanotechnologies 147
In vivo Myogenic Potential of Human CD133+ Muscle-derived Stem Cells: A quantitative Study 145
Perturbation of calcium handling in CD133+ stem cells isolated from DMD blood 141
Stem Cell Salvage of injured peripheral nerve 141
Proliferation and clonal Characterization of Human Muscle Derived CD133+ Stem Cell Define an Intrinsic Heterogeneity 138
Exon-Skipping of Dysferlin in CD133+ Stem Cells Isolated from normal and patient affected with Dysferlinopathies 135
Proliferation and Clonal Characterization of Human muscle Derived CD 133+ stem cell Define an Heterogeneity 134
Difference in Myogenic properties of the human blood-derived stem cells subpopulation isolated from normal and dystrophic tissues 123
Exon-skipping of dysferlin in CD133+ stem cells isolated from normal and patient affected with dysferlinopathies 119
Combining stem cells and exon skipping strategy to treat dystrophic GRMD dogs 116
Novel insight into stem cell trafficking in dystrophic muscles 113
Full-Length Dysferlin Expression Driven by Engineered Human Dystrophic Blood-Derived CD133+ Stem Cells 84
null 47
Stem cell salvage of injured peripheral nerve 7
Autologous transplantation of bone marrow-derived CD133+stem cells in facioscapulohumeral dystrophy 7
Stem cell therapy of muscular dystrophies using exon skipping approach in GRMD dogs 5
Combining gene and stem cell therapy in the treatment of dysferlinophaties 3
Totale 9.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022518 0 21 4 31 28 36 57 15 71 36 69 150
2022/2023963 142 105 86 87 113 167 9 74 138 6 22 14
2023/2024542 18 34 15 40 153 24 33 33 11 47 55 79
2024/20251.408 54 120 34 204 105 21 83 127 55 189 81 335
2025/20262.579 290 137 186 183 261 181 402 135 244 202 182 176
2026/2027156 124 32 0 0 0 0 0 0 0 0 0 0
Totale 9.981